Ten recommendations for closing the credibility gap in reporting industry-sponsored clinical research: a joint journal and pharmaceutical industry perspective

Affiliations

Bernadette A Mansi et al. Mayo Clin Proc.2012 May.

.2012 May;87(5):424-9.

doi: 10.1016/j.mayocp.2012.02.009.

No abstract available

Comment in

Commenting on ten recommendations for closing the credibility gap in reporting industry-sponsored clinical research.
Stossel TP, Stell LK.Stossel TP, et al.Mayo Clin Proc. 2012 Sep;87(9):925-6; author reply 926. doi: 10.1016/j.mayocp.2012.06.020.Mayo Clin Proc. 2012.PMID:22958997Free PMC article.No abstract available.

1. Bruyere O., Kanis J.A., Ibar-Abadie M.E. The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Rest of Ethics and Excellent in Science (GREES) Osteopor Int. 2010;21(5):713–722. - PubMed
1. Pyke S., Julious S.A., Day S. The potential for bias in reporting of industry-sponsored clinical trials. Pharm Stats. 2011;10(1):74–79. - PubMed
1. Strahlman E., Rockhold F., Freeman A. Public disclosure of clinical research. Lancet. 2009;373(9672):1319–1320. - PubMed
1. PhRMA Principles on Conduct of Clinical Trials: Communication of Clinical Trial Results.http://www.phrma.org/sites/default/files/105/042009_clinical_trial_princ... PhRMA Web site. Accessed January 31, 2012.
1. Amgen Amgen Guidelines for Publications.http://www.amgen.com/about/amgen_guidelines_for_publications.html Amgen Web site. Accessed January 31, 2012.